186
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Off-label venetoclax in combination with hypomethylating agents for post-allogeneic stem cell transplant acute myeloid leukemia relapse

ORCID Icon, , , , , , , , , , , & show all
Pages 2743-2746 | Received 21 Mar 2022, Accepted 07 Jun 2022, Published online: 22 Jun 2022
 

Author contributions

FS, MS, NSF and FO designed the study. FS and MS assessed patients for eligibility and collected data. FS analyzed data and designed tables and figures. FS, MS, NSF and FO contributed to manuscript development. All authors approved the final manuscript for submission. NSF and FO equally contributed to the manuscript.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This study was funded by Italian Ministry of Health - Current research IRCCS.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.